The dietary supplement industry is abuzz with the news of the FDA's proposed changes to Generally Recognized As Safe (GRAS) notifications. While the agency's intentions may be good, Todd Harrison, a partner at Venable LLP, warns that these changes could create significant legal and policy hurdles. Harrison's analysis highlights the potential impact on ingredient suppliers and functional food and beverage companies, as well as the broader implications for the industry.
One of the main concerns is the FDA's authority to mandate GRAS notifications. Harrison points out that the Federal Food, Drug, and Cosmetic Act (FD&C Act) does not explicitly require companies to submit these notifications. This lack of clarity could lead to uncertainty and legal challenges. The agency's previous stance on its lack of authority to mandate notifications further complicates matters.
The proposal's potential impact on the functional beverage market is particularly alarming. Harrison suggests that if the proposal were to withstand judicial scrutiny, it could effectively end the functional beverage space. This is because dietary ingredients are increasingly appearing in consumer packaged goods, and the proposal's requirements could make it difficult for companies to navigate the regulatory landscape.
Another issue is the lack of a clear remedy or final agency decision for companies when the FDA disagrees with their GRAS determination. This could leave businesses exposed to commercial consequences even without formal FDA enforcement. Additionally, the proposal's potential burden on ingredient suppliers and the growing functional food and beverage market cannot be overlooked.
The legal vulnerability of the proposal is further heightened by the Supreme Court's 2024 Loper Bright decision, which ended Chevron deference and requires courts to independently determine the best interpretation of a statute. Harrison believes that the agency will have a hard time in court, as the proposal's rationale may not be strong enough to withstand judicial scrutiny.
In conclusion, while the FDA's proposed changes to GRAS notifications may have good intentions, they could create significant legal and policy hurdles. The potential impact on ingredient suppliers, functional food and beverage companies, and the broader industry cannot be ignored. It is crucial for the agency to carefully consider the implications of its proposal and ensure that it is well-supported by legal and policy justifications.
